Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-21,036
Closed -$1.33M 914
2021
Q4
$1.33M Buy
21,036
+2,954
+16% +$233K 0.1% 304
2021
Q3
$1.86M Buy
18,082
+4,711
+35% +$532K 0.13% 252
2021
Q2
$1.44M Buy
13,371
+450
+3% +$33.7K 0.1% 308
2021
Q1
$690K Hold
12,921
0.05% 445
2020
Q4
$806K Hold
12,921
0.05% 367
2020
Q3
$1.01M Buy
+12,921
New +$1.01M 0.07% 302
2020
Q1
Sell
-1,077
Closed -$86K 646
2019
Q4
$86K Buy
+1,077
New +$72.3K 0.01% 694

Other funds holding AGEN

PDT Partners's AGEN Position: Q1 2022 in Review

PDT Partners sold out of Agenus (AGEN) in Q1 2022, closing a stake of 21,036 shares — an estimated $1.33M sold.

PDT Partners first reported a position in AGEN in Q4 2019 and held it in 7 quarters. The position peaked at $1.86M in Q3 2021. 170 funds tracked by Wall St. Rank hold AGEN as of Q1 2022.

  • PDT Partners reported no remaining Agenus position as of Q1 2022 after selling out during the quarter.
  • PDT Partners sold 21,036 Agenus shares in Q1 2022, an estimated $1.33M.
  • PDT Partners first reported a position in Agenus in Q4 2019 and held it in 7 quarters.
  • PDT Partners's Agenus position peaked at $1.86M in Q3 2021.
  • 170 funds tracked by Wall St. Rank held Agenus as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.